Abstract

A specific, simple, sensitive Ultra High Performance Liquid Chromatography-tandem Mass Spectrometry (UHPLC-MS/MS) method has been developed and validated for the simultaneous determination and pharmacokinetic study of purpurin, munjistin, and mollugin in rat plasma. Chromatographic separation was carried out using a C18 column (ACQUITY UPLC® HSS T3, 1.8 μm, 2.1 × 100 mm) with gradient elution. The compounds were detected on a 6430 triple-quadrupole tandem MS with an electrospray ionization (ESI) interface using multiple reaction monitoring (MRM) in positive ionization mode. The samples were prepared by a liquid-liquid extraction (LLE) method with ethyl acetate after being spiked with an internal standard (bifendate). The current UHPLC-MS/MS assay was validated for its linearity, intra-day and inter-day precisions, accuracy, extraction recovery, matrix effect and stability in different conditions. The method was linear for all analytes over the investigated range with all determined correlation coefficients exceeding 0.9900. The intra-day and inter-day precisions were in the range of 4.21% to 14.84%, and the relative errors of accuracies were in the range of −14.05% to 14.75%. The mean recoveries and matrix effects of purpurin, munjistin, and mollugin were higher than 78.87% and 92.56%, repectively. After oral administration of 0.82 g/kg of Rubia cordifolia extract, the maximum plasma concentrations (Cmax) were 70.10 ± 11.78 ng/mL for purpurin, 26.09 ± 6.6 ng/mL for munjistin, and 52.10 ± 6.71 ng/mL for mollugin. The time for maximal concentration (Tmax) was 1.61 ± 0.24 h for purpurin, 2.58 ± 0.19 h for munjistin, and 1.99 ± 0.21 h for mollugin. The established method was further applied to a pharmacokinetic study of purpurin, munjistin, and mollugin in rat plasma. It was concluded from the pharmacokinetic parameters that the three analytes showed a process of slow absorption and metabolism after oral administration of R. cordifolia extract to rats.

Highlights

  • Rubia cordifolia L., belonging to the genus Rubia (Rubiaceae), is a type of perennial herb, distributed

  • We have developed for the first time a tested sensitive and selective UHPLC-MS/MS method to simultaneously determine munjistin, purpurin, and mollugin in rat plasma

  • The intra- and inter-day precisions (RSD) of the three analytes were less than 14.99%, and the Quality Control (QC) level, the intra- and inter-day precisions (RSD) of the three analytes were less than 14.99%, and accuracy ranged from14.05% to 14.75%

Read more

Summary

Introduction

Rubia cordifolia L., belonging to the genus Rubia (Rubiaceae), is a type of perennial herb, distributed. Purpurinare and the main indicator compounds for this composition in the Purpurin and mollugin have been reported to possess antioxidant and enzyme inhibition activities. Mollugin have been reported to possess antioxidant and enzyme inhibition activities. Purpurin showed stronger antioxidant and better enzyme inhibitory effects than mollugin [10]. We have developed for the first time a tested sensitive and selective UHPLC-MS/MS method to simultaneously determine munjistin, purpurin, and mollugin in rat plasma. The validated method has been successfully applied to the time a tested sensitive and selective UHPLC-MS/MS method to simultaneously determine munjistin, purpurin, and 21, mollugin in rat plasma. Study could provide some useful references for the further pharmacological study of R. cordifolia

Results and Discussion
Sample Preparation
Specificity and Selectivity
Linearity and Lower
Precision and Accuracy
Extraction Recovery and Matrix Effect
Stability Experiments
Application to the Pharmacokinetic Study
Materials and Reagents
Instruments and Analytical Conditions
Animal Experiments
Plasma Sample Preparation
Method Validation
Application to Pharmacokinetic Study
Conclusions

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.